 |
Board of Directors
James
M. Cornelius
Chairman and Chief Executive Officer (d)
Lewis
B. Campbell
Lead Independent Director, Bristol-Myers Squibb, and Chairman, President
and Chief Executive Officer, Textron Inc. (a,b,c)
Louis
J. Freeh
President,
Freeh Group International Solutions, LLC and Managing Partner,
Freeh Sullivan Sporkin, LLP (a,b)
Laurie
H. Glimcher, M.D.
Irene Heinz Given Professor of Immunology, Harvard School of Public
Health, and Professor of Medicine, Harvard Medical School (a,b,d)
Michael Grobstein
Retired Vice Chairman, Ernst & Young (a,c)
Leif
Johansson
President, AB Volvo, and Chief Executive Officer, The Volvo Group
(a,c)
Alan
J. Lacy
Senior Advisor, Oak Hill Capital Partners, L.P. (a)
James
D. Robinson III
Cofounder and General Partner, RRE Ventures
Vicki
L. Sato, Ph.D.
Professor of Management Practice, Harvard Business School, and Professor
of Molecular and Cell Biology, Harvard University (c,d)
Togo
D. West Jr.
Chairman, TLI Leadership Group and Noblis, Inc. (b,c)
R.
Sanders Williams, M.D.
Senior Vice Chancellor for Academic Affairs, Duke University (b,d)
(a)
Audit Committee
(b) Committee on Directors and Corporate Governance
(c) Compensation and Management Development Committee
(d) Science and Technology Committee
|
